Announcements A Joint Statement on Technical, legal, ethical and implementation concerns regarding Aarogya Setu and other apps introduced during COVID-19 in India by Jan Swasthya Abhiyan (JSA), Internet Freedom Foundation (IFF), Forum for Medical Ethics Society (FMES), and All India People’s Science Network (AIPSN)   |   Submission to the National Human Rights Commission (NHRC) on behalf of Hub5 (HEaL Institute, APU, Seher-CHSJ, and IAPH) – COPASAH on human rights issues confronted by ASHAS and ANMs during the Covid-19 pandemic | Aug 7, 2020   |   Letter to MMC by FMES, PUCL-MH, FAOW, and MFC urging to restore its order suspending licenses of two doctors accused of abetting the suicide of Dr Payal Tadvi

Why should I not prescribe branded drugs?

Yash Paul

DOI: 10.20529/IJME.2012.045


A branded drug costs more than the same molecule available as a generic drug. Some state governments have issued instructions to doctors to prescribe only generic drugs, failing which punitive action may be taken against them. The intention appears to be good: to provide drugs to people at a low cost. However, this may act as a double-edged sword: making drugs available at a lower cost, but of an inferior quality. It is presumed that reputed pharma houses maintain stringent quality control of their products as their reputation is at stake. The same may be true of unbranded products also. But, the market is currently flooded with spurious or sub-standard drugs.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US